Shanghai GenTech Future Growth

Future criteria checks 5/6

Shanghai GenTech is forecast to grow earnings and revenue by 29.2% and 25.9% per annum respectively. EPS is expected to grow by 28.2% per annum. Return on equity is forecast to be 18.5% in 3 years.

Key information

29.2%

Earnings growth rate

28.2%

EPS growth rate

Semiconductor earnings growth	39.0%
Revenue growth rate	25.9%
Future return on equity	18.5%
Analyst coverage	Low
Last updated	05 Jun 2024

Recent future growth updates

Recent updates

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Mar 03

Earnings and Revenue Growth Forecasts

SHSE:688596 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	8,665	975	N/A	474	3
12/31/2025	7,148	787	N/A	288	3
12/31/2024	5,707	593	N/A	358	3
3/31/2024	4,013	415	-382	35	N/A
12/31/2023	3,835	401	-245	116	N/A
9/30/2023	3,312	392	-39	251	N/A
6/30/2023	3,106	356	-118	95	N/A
3/31/2023	2,753	259	-500	-275	N/A
12/31/2022	2,705	259	-422	-162	N/A
9/30/2022	2,405	198	-360	-93	N/A
6/30/2022	1,992	167	-379	-69	N/A
3/31/2022	2,027	179	-246	1	N/A
12/31/2021	1,837	168	-207	-20	N/A
9/30/2021	1,669	186	-111	3	N/A
6/30/2021	1,452	152	-64	-11	N/A
3/31/2021	1,170	132	2	41	N/A
12/31/2020	1,109	124	-85	-56	N/A
9/30/2020	1,172	116	-34	-3	N/A
6/30/2020	1,118	94	68	98	N/A
3/31/2020	1,181	90	15	57	N/A
12/31/2019	1,186	83	45	85	N/A
12/31/2018	921	60	90	110	N/A
12/31/2017	707	31	N/A	-43	N/A
6/30/2017	708	28	N/A	-36	N/A
3/31/2017	644	24	N/A	-6	N/A
12/31/2016	580	21	N/A	25	N/A
9/30/2016	540	21	N/A	30	N/A
6/30/2016	501	21	N/A	35	N/A
3/31/2016	506	17	N/A	15	N/A
12/31/2015	512	12	N/A	-4	N/A
12/31/2014	498	16	N/A	47	N/A
12/31/2013	216	-4	N/A	55	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688596's forecast earnings growth (29.2% per year) is above the savings rate (2.9%).

Earnings vs Market: 688596's earnings (29.2% per year) are forecast to grow faster than the CN market (22.3% per year).

High Growth Earnings: 688596's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688596's revenue (25.9% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 688596's revenue (25.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688596's Return on Equity is forecast to be low in 3 years time (18.5%).

Shanghai GenTech Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Price target decreased by 9.8% to CN¥46.00

Price target decreased by 9.4% to CN¥52.00

Price target decreased by 12% to CN¥50.50

Recent updates

Shanghai GenTech Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Sentiment Still Eluding Shanghai GenTech Co., Ltd. (SHSE:688596)

Price target decreased by 9.8% to CN¥46.00

Do Shanghai GenTech's (SHSE:688596) Earnings Warrant Your Attention?

New minor risk - Dividend sustainability

Shanghai GenTech's (SHSE:688596) Profits May Not Reveal Underlying Issues

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.04 in 1Q 2023)

Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Shanghai GenTech Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Returns On Capital At Shanghai GenTech (SHSE:688596) Have Stalled

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Full year 2023 earnings: EPS exceeds analyst expectations

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares.

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.33 in 3Q 2022)

Price target decreased by 9.4% to CN¥52.00

Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.19 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 1Q 2022)

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 12% to CN¥50.50

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.21 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai GenTech Co., Ltd. announced that it expects to receive CNY 300 million in funding

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 120 million worth of its shares.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.09 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.17 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.07 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.48 (vs CN¥0.45 in FY 2019)

New 90-day low: CN¥15.90

Investor sentiment deteriorated over the past week

New 90-day low: CN¥18.86

New 90-day low: CN¥20.75

Shanghai GenTech Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

First half earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies